Literature DB >> 19359473

Inositol phosphatase SHIP1 is a primary target of miR-155.

Ryan M O'Connell1, Aadel A Chaudhuri, Dinesh S Rao, David Baltimore.   

Abstract

MicroRNA-155 (miR-155) has emerged as a critical regulator of immune cell development, function, and disease. However, the mechanistic basis for its impact on the hematopoietic system remains largely unresolved. Because miRNAs function by repressing specific mRNAs through direct 3'UTR interactions, we have searched for targets of miR-155 implicated in the regulation of hematopoiesis. In the present study, we identify Src homology-2 domain-containing inositol 5-phosphatase 1 (SHIP1) as a direct target of miR-155, and, using gain and loss of function approaches, show that miR-155 represses SHIP1 through direct 3'UTR interactions that have been highly conserved throughout evolution. Repression of endogenous SHIP1 by miR-155 occurred following sustained over-expression of miR-155 in hematopoietic cells both in vitro and in vivo, and resulted in increased activation of the kinase Akt during the cellular response to LPS. Furthermore, SHIP1 was also repressed by physiologically regulated miR-155, which was observed in LPS-treated WT versus miR-155(-/-) primary macrophages. In mice, specific knockdown of SHIP1 in the hematopoietic system following retroviral delivery of a miR-155-formatted siRNA against SHIP1 resulted in a myeloproliferative disorder, with striking similarities to that observed in miR-155-expressing mice. Our study unveils a molecular link between miR-155 and SHIP1 and provides evidence that repression of SHIP1 is an important component of miR-155 biology.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19359473      PMCID: PMC2678424          DOI: 10.1073/pnas.0902636106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  48 in total

1.  High expression of B-cell receptor inducible gene BIC in all subtypes of Hodgkin lymphoma.

Authors:  Anke van den Berg; Bart-Jan Kroesen; Klaas Kooistra; Debora de Jong; Jane Briggs; Tjasso Blokzijl; Susan Jacobs; Joost Kluiver; Arjan Diepstra; Ewerton Maggio; Sibrand Poppema
Journal:  Genes Chromosomes Cancer       Date:  2003-05       Impact factor: 5.006

Review 2.  Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs.

Authors:  David P Bartel; Chang-Zheng Chen
Journal:  Nat Rev Genet       Date:  2004-05       Impact factor: 53.242

Review 3.  The termination of PI3K signalling by SHIP1 and SHIP2 inositol 5-phosphatases.

Authors:  Katrien Backers; Daniel Blero; Nathalie Paternotte; Jing Zhang; Christophe Erneux
Journal:  Adv Enzyme Regul       Date:  2003

Review 4.  SHIP, SHIP2, and PTEN activities are regulated in vivo by modulation of their protein levels: SHIP is up-regulated in macrophages and mast cells by lipopolysaccharide.

Authors:  Laura M Sly; Michael J Rauh; Janet Kalesnikoff; Tom Büchse; Gerald Krystal
Journal:  Exp Hematol       Date:  2003-12       Impact factor: 3.084

5.  Homeostasis and regeneration of the hematopoietic stem cell pool are altered in SHIP-deficient mice.

Authors:  Cheryl D Helgason; Jennifer Antonchuk; Caroline Bodner; R Keith Humphries
Journal:  Blood       Date:  2003-07-10       Impact factor: 22.113

6.  MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb.

Authors:  Changchun Xiao; Dinis Pedro Calado; Gunther Galler; To-Ha Thai; Heide Christine Patterson; Jing Wang; Nikolaus Rajewsky; Timothy P Bender; Klaus Rajewsky
Journal:  Cell       Date:  2007-10-05       Impact factor: 41.582

Review 7.  The role of SHIP in cytokine-induced signaling.

Authors:  J Kalesnikoff; L M Sly; M R Hughes; T Büchse; M J Rauh; L-P Cao; V Lam; A Mui; M Huber; G Krystal
Journal:  Rev Physiol Biochem Pharmacol       Date:  2003-04-12       Impact factor: 5.545

8.  Mutation analysis of SHIP gene in acute leukemia.

Authors:  Jian-Min Luo; Ze-Lin Liu; Hong-Ling Hao; Fu-Xu Wang; Zuo-Ren Dong; Ryuzo Ohno
Journal:  Zhongguo Shi Yan Xue Ye Xue Za Zhi       Date:  2004-08

9.  Possible dominant-negative mutation of the SHIP gene in acute myeloid leukemia.

Authors:  J-M Luo; H Yoshida; S Komura; N Ohishi; L Pan; K Shigeno; I Hanamura; K Miura; S Iida; R Ueda; T Naoe; Y Akao; R Ohno; K Ohnishi
Journal:  Leukemia       Date:  2003-01       Impact factor: 11.528

10.  A dual role for Src homology 2 domain-containing inositol-5-phosphatase (SHIP) in immunity: aberrant development and enhanced function of b lymphocytes in ship -/- mice.

Authors:  C D Helgason; C P Kalberer; J E Damen; S M Chappel; N Pineault; G Krystal; R K Humphries
Journal:  J Exp Med       Date:  2000-03-06       Impact factor: 14.307

View more
  372 in total

1.  Interferon regulatory factor 3 inhibits astrocyte inflammatory gene expression through suppression of the proinflammatory miR-155 and miR-155*.

Authors:  Leonid Tarassishin; Olivier Loudig; Avital Bauman; Bridget Shafit-Zagardo; Hyeon-Sook Suh; Sunhee C Lee
Journal:  Glia       Date:  2011-12       Impact factor: 7.452

2.  MicroRNA-301a regulation of a T-helper 17 immune response controls autoimmune demyelination.

Authors:  Marcin P Mycko; Maria Cichalewska; Agnieszka Machlanska; Hanna Cwiklinska; Magdalena Mariasiewicz; Krzysztof W Selmaj
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-18       Impact factor: 11.205

3.  EBV and human microRNAs co-target oncogenic and apoptotic viral and human genes during latency.

Authors:  Kasandra J Riley; Gabrielle S Rabinowitz; Therese A Yario; Joseph M Luna; Robert B Darnell; Joan A Steitz
Journal:  EMBO J       Date:  2012-03-30       Impact factor: 11.598

4.  miR-155 regulates IFN-γ production in natural killer cells.

Authors:  Rossana Trotta; Li Chen; David Ciarlariello; Srirama Josyula; Charlene Mao; Stefan Costinean; Lianbo Yu; Jonathan P Butchar; Susheela Tridandapani; Carlo M Croce; Michael A Caligiuri
Journal:  Blood       Date:  2012-02-29       Impact factor: 22.113

Review 5.  Functional regulation of monocyte-derived dendritic cells by microRNAs.

Authors:  Yifan Zhan; Li Wu
Journal:  Protein Cell       Date:  2012-07-10       Impact factor: 14.870

6.  miRNA-based mechanism for the commitment of multipotent progenitors to a single cellular fate.

Authors:  Mati Mann; Omer Barad; Reuven Agami; Benjamin Geiger; Eran Hornstein
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-18       Impact factor: 11.205

7.  MicroRNAs enriched in hematopoietic stem cells differentially regulate long-term hematopoietic output.

Authors:  Ryan M O'Connell; Aadel A Chaudhuri; Dinesh S Rao; William S J Gibson; Alejandro B Balazs; David Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-26       Impact factor: 11.205

8.  Deletion of microRNA-155 reduces autoantibody responses and alleviates lupus-like disease in the Fas(lpr) mouse.

Authors:  To-Ha Thai; Heide Christine Patterson; Duc-Hung Pham; Katalin Kis-Toth; Denise A Kaminski; George C Tsokos
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-26       Impact factor: 11.205

Review 9.  MicroRNAs in immune response and macrophage polarization.

Authors:  Gang Liu; Edward Abraham
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-02       Impact factor: 8.311

10.  MicroRNA 155 regulates Japanese encephalitis virus-induced inflammatory response by targeting Src homology 2-containing inositol phosphatase 1.

Authors:  Menaka Chanu Thounaojam; Kiran Kundu; Deepak Kumar Kaushik; Shalini Swaroop; Anita Mahadevan; Susarla Krishna Shankar; Anirban Basu
Journal:  J Virol       Date:  2014-02-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.